Issue link: https://www.e-digitaleditions.com/i/807837
8 April 2017 Tablets & Capsules research Capsule powered by stomach fluid can run sensors, deliver APIs CAMBRIDGE, MA—Researchers at the Massachusetts Institute of Technology and Brigham and Women's Hospital developed a cap- sule that uses stomach acid to power sensors and can remain in the gas- trointestinal tract for extended peri- ods. The capsule has external zinc and copper electrodes that react with stomach acid to generate electricity and power small sensors that can monitor vital signs and deliver APIs. In tests on pigs, the capsules took 6 days on average to travel through the digestive tract. The device could be useful in experiments that deliver dif- ferent doses of APIs. An article about the capsule study appears in the February issue of Nature Biomedical Engineering. markets Report forecasts 6.6 percent annual growth in outsourcing market NEW YORK, NY—Outsourced manufacturing is the fastest growing sector of the pharmaceutical market, growing at a rate of 6.6 percent per year, according to a report from Results Healthcare. It forecasts that the value of the outsourcing market will reach $105 billion in 2021. Oral solid dosage products account for about 48.5 percent of the market and about 92 percent of the market is currently dedicated to small-mole- cule commercial manufacturing sup- ply. The report, "Pharma & Biotech 2017," forecasts that volume-driven generics will stoke demand for small molecules. It also notes that clinical manufacturing helps lock in clients but isn't a central source of revenue for most contract manufacturing organizations (CMOs). The group's previous report on the CMO sector appeared in 2013. Market for capsule filling equipment to grow almost 5 percent annually ALBANY, NY—A preference for capsules, especially for use with dietary supplements, will drive the demand for automatic capsule filling equipment, according to a report from Transparency Market Research. The report predicts the global mar- ket for capsule filling equipment will grow at a compound annual rate of 4.9 percent, reaching $845.1 million by the end of 2024. Report assesses growth factors for oral solid dosage market VALLEY COTTAGE, NY—The increasing number of new molecular entities gaining approval will drive the market for oral dosage pharma- ceuticals through 2027, according to a report by Future Markets Insights. Other growth factors include phar- maceutical industry consolidation; greater availability of off-patent fixed-dose combinations, extended- release formulations, and pediatric forms; and the adoption of nontradi- SANITARY/USDA-ACCEPTED • PNEUMATIC CONVEYING COMPONENTS & SYSTEMS • BATCH & CONTINUOUS OPERATION MULTI-INGREDIENT HANDLING SYSTEMS • BATCH WEIGHING & SCALING SYSTEMS • UL-CONTROLS & CONTROL PACKAGES FDA-APPROVED/CERTIFIED MATERIALS OF CONSTRUCTION • 21 CFR PART 11 COMPLIANCE MOBILE VACUUM CONVEYING SYSTEMS • CIP DESIGNS Let us solve your pneumatic conveying challenges. Visit vac-u-max.com/pneumatic or call 800-VAC-U-MAX. More than 60 years of custom application experience in the pharmaceutical industry. Over 10,000 different powder and bulk materials handled—including Free-Flowing and Non-Free Flowing Powders. Technical expertise including FAT and SAT validation. And an airtight perfor- mance guarantee. It's what makes VAC-U-MAX as unique and trusted as the pharmaceutical process automation solutions we design. From sanitary components to fully automated batch or continuous systems, we create pharmaceutical processing solutions entirely around your needs and goals.